Physician Wealth Advisors’s Sigma Lithium SGML Stock Holding History

Physician Wealth Advisors’s Portfolio SGML Stock Details SGML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41	Closed	-$541	–	2214
2025 Q4	$541	Buy	+41	New	+$353	﹤0.01%	1843

Other funds holding SGML

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Dayah Capital Stamford, Connecticut $261M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Physician Wealth Advisors's SGML Position: Q1 2026 in Review

Physician Wealth Advisors sold out of Sigma Lithium (SGML) in Q1 2026, closing a stake of 41 shares — an estimated $541 sold.

Physician Wealth Advisors first reported a position in SGML in Q4 2025 and held it in 1 quarter. The position peaked at $541 in Q4 2025. 94 funds tracked by Wall St. Rank hold SGML as of Q1 2026.

Physician Wealth Advisors reported no remaining Sigma Lithium position as of Q1 2026 after selling out during the quarter.
Physician Wealth Advisors sold 41 Sigma Lithium shares in Q1 2026, an estimated $541.
Physician Wealth Advisors first reported a position in Sigma Lithium in Q4 2025 and held it in 1 quarter.
Physician Wealth Advisors's Sigma Lithium position peaked at $541 in Q4 2025.
94 funds tracked by Wall St. Rank held Sigma Lithium as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.